ZA201406567B - Method for treatment of labor arrest - Google Patents

Method for treatment of labor arrest

Info

Publication number
ZA201406567B
ZA201406567B ZA2014/06567A ZA201406567A ZA201406567B ZA 201406567 B ZA201406567 B ZA 201406567B ZA 2014/06567 A ZA2014/06567 A ZA 2014/06567A ZA 201406567 A ZA201406567 A ZA 201406567A ZA 201406567 B ZA201406567 B ZA 201406567B
Authority
ZA
South Africa
Prior art keywords
treatment
labor arrest
arrest
labor
Prior art date
Application number
ZA2014/06567A
Other languages
English (en)
Inventor
Anders Malmström
Gunvor Ekman-Ordeberg
Original Assignee
Dilafor Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dilafor Ab filed Critical Dilafor Ab
Publication of ZA201406567B publication Critical patent/ZA201406567B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727Heparin; Heparan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • A61K38/095Oxytocins; Vasopressins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ZA2014/06567A 2012-03-26 2014-09-08 Method for treatment of labor arrest ZA201406567B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261615400P 2012-03-26 2012-03-26
PCT/SE2013/050333 WO2013147690A1 (en) 2012-03-26 2013-03-25 Method for treatment of labor arrest

Publications (1)

Publication Number Publication Date
ZA201406567B true ZA201406567B (en) 2017-06-28

Family

ID=49260784

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2014/06567A ZA201406567B (en) 2012-03-26 2014-09-08 Method for treatment of labor arrest

Country Status (15)

Country Link
US (1) US20150057226A1 (enExample)
EP (1) EP2830634A4 (enExample)
JP (1) JP2015514705A (enExample)
CN (1) CN104244957B (enExample)
AU (1) AU2013240598A1 (enExample)
CA (1) CA2868479A1 (enExample)
HK (1) HK1203370A1 (enExample)
MX (1) MX2014011451A (enExample)
MY (1) MY185108A (enExample)
NZ (1) NZ631279A (enExample)
RU (1) RU2014143008A (enExample)
SG (1) SG11201406118QA (enExample)
UA (1) UA117907C2 (enExample)
WO (1) WO2013147690A1 (enExample)
ZA (1) ZA201406567B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
SMT201800143T1 (it) 2011-12-19 2018-05-02 Dilafor Ab Glicosaminoglicani non anticoagulanti comprendenti un'unita ripetitiva di disaccaridi e loro uso medico
SG10201607872PA (en) 2012-03-26 2016-11-29 Santen Pharmaceutical Co Ltd Ophthalmic solution comprising diquafosol
CA2868403A1 (en) * 2012-05-08 2013-11-14 Dilafor Ab Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent
KR20220142508A (ko) 2020-02-17 2022-10-21 딜라포 아베 자간전증 치료용 타폭시파린
CA3255831A1 (en) 2022-05-03 2023-11-09 Dilafor Ab NEW MEDICAL USE OF TAFOXIPARIN
EP4272749A1 (en) 2022-05-03 2023-11-08 Dilafor AB New medical use of tafoxiparin
AU2024213271A1 (en) * 2023-02-01 2025-07-17 Materna Medical, Inc. Methods and apparatus for preventing vaginal lacerations during childbirth

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000065837A (ja) * 1998-08-24 2000-03-03 Seikagaku Kogyo Co Ltd グリコサミノグリカン又はグリコサミノグリカン結合性分子の測定方法及びその測定用キット
JP2000309544A (ja) * 1999-02-25 2000-11-07 Seikagaku Kogyo Co Ltd 早産または流産防止剤および子宮頚管熟化抑制剤ならびにヒアルロニダーゼの阻害剤
SE521676C2 (sv) * 2002-01-02 2003-11-25 Dilafor Ab Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
US8445436B2 (en) * 2007-12-03 2013-05-21 Florida State University Research Foundation, Inc. Oxytocin and melatonin compositions and associated methods for inducing labor
SMT201800143T1 (it) * 2011-12-19 2018-05-02 Dilafor Ab Glicosaminoglicani non anticoagulanti comprendenti un'unita ripetitiva di disaccaridi e loro uso medico

Also Published As

Publication number Publication date
AU2013240598A1 (en) 2014-10-02
CA2868479A1 (en) 2013-10-03
HK1203370A1 (en) 2015-10-30
SG11201406118QA (en) 2014-11-27
WO2013147690A1 (en) 2013-10-03
MX2014011451A (es) 2014-11-10
EP2830634A1 (en) 2015-02-04
NZ631279A (en) 2016-06-24
JP2015514705A (ja) 2015-05-21
MY185108A (en) 2021-04-30
CN104244957A (zh) 2014-12-24
CN104244957B (zh) 2017-11-17
US20150057226A1 (en) 2015-02-26
RU2014143008A (ru) 2016-05-20
UA117907C2 (uk) 2018-10-25
EP2830634A4 (en) 2016-01-20

Similar Documents

Publication Publication Date Title
GB201110095D0 (en) Method of treatment
EP2773754A4 (en) Methods of Treatment
IL237791A0 (en) A method for treating cancer
EP2717855A4 (en) PROCESSING METHODS
SG11201503893RA (en) Method of treating cancer
EP2879688A4 (en) METHODS OF TREATING ATHEROSCLEROSIS
ZA201408353B (en) Method of treating hair
PT2857019T (pt) Método de tratamento de esclerose múltipla
ZA201408342B (en) Method of treating hair
EP2895206A4 (en) METHOD FOR TREATING CARCINOMA
ZA201406567B (en) Method for treatment of labor arrest
IL239273A0 (en) A method of treating diseases
ZA201407575B (en) Method for treating gynecological diseases
EP2812338A4 (en) METHOD FOR THE TREATMENT OF NASOPHARYNGEAL CANCER
GB201215942D0 (en) Method of treatent
ZA201503833B (en) Method of hemoglobin-f determination
ZA201407215B (en) Method for emulsion treatment
EP2791324A4 (en) PROCESSING METHOD
EP2911662A4 (en) METHOD OF TREATING A DISEASE
GB201221032D0 (en) Method of treatment
GB201207894D0 (en) Method of treatment
GB201221118D0 (en) Methods of treatment
GB201216748D0 (en) Methods of treatment
GB201216740D0 (en) Methods of treatment
GB201206330D0 (en) Methods of treatment